China Fishery Group Ltd., the biggest anchovy-quota holder in Peru following its acquisition of Oslo-listed Copeinca ASA, may be downgraded after the buyout sent its debt levels soaring.
Amarin Corp., the maker of the fish oil pill Vascepa, asked a federal judge to order the U.S. Food and Drug Administration to give it exclusive marketing rights to the product for five years.
Women with high blood levels of fish oils have larger brain volumes then those with lower levels, suggesting the oils may delay the normal loss of brain cells due to aging, research found.
A ruling on Amarin Corp.’s application to expand use of its fish-oil pill was delayed by the Food and Drug Administration as the agency considers the company’s appeal of a requirement for more study on the drug.
Fish oil has been touted as useful for everything from growing hair to treating clinical depression. Now drug makers are stepping up their promotion of its benefits for treating heart disease.
Taking fish oil before and after cardiac surgery didn’t prevent a form of irregular heartbeat in a study finding that raises more questions about the extent of the supplement’s health benefits.
Amarin Corp. lost more than half its value after the company failed to win the backing of U.S. advisers to expand use of its fish-oil pill Vascepa for those with high levels of fat in their blood.
Expanding the use of Amarin Corp.’s fish oil drug Vascepa, approved last year to treat “very high” triglycerides, may depend on the outcome of a study on heart risks, U.S. regulators said.
Amarin’s fish-oil pill Vascepa failed to win the backing of U.S. advisers to significantly expand its use for those with high levels of fat in their blood.
The consumption of polyunsaturated fatty acids found primarily in fish is linked to a 14 percent decline in breast-cancer risk, according to a new study.